Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Emerg Infect Dis ; 26(11): 2678-2684, 2020 11.
Article in English | MEDLINE | ID: mdl-33079034

ABSTRACT

We retrospectively assessed the effectiveness of azithromycin in preventing transmission of pertussis to a patient's household contacts. We also considered the duration between symptom onset in the primary patient and azithromycin administration. We categorized contacts into 4 groups: those treated within <7 days, 8-14 days, 15-21 days, and >21 days after illness onset in the primary patient. We studied 476 primary index patients and their 1,975 household contacts, of whom 4.5% were later identified as having pertussis. When contacts started chemoprophylaxis within <21 days after the primary patient's symptom onset, the treatment was 43.9% effective. Chemoprophylaxis started >14 days after primary patient's symptom onset was less effective. We recommend that contacts of persons with pertussis begin chemoprophylaxis within <14 days after primary patient's symptom onset.


Subject(s)
Antibiotic Prophylaxis , Azithromycin , Whooping Cough , Adolescent , Adult , Azithromycin/therapeutic use , Bordetella pertussis , Child , Child, Preschool , Female , Humans , Infant , Male , Retrospective Studies , Spain/epidemiology , Whooping Cough/drug therapy , Whooping Cough/epidemiology , Whooping Cough/prevention & control , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...